Market Overview

Benzinga's Top #PreMarket Gainers

Related EXEL
Top Stock Reports for Comcast, Honeywell & General Motors
Mid-Day Market Update: Red Hat Rises After Strong Q1 Results; CIRCOR Shares Slide
Related PGNX
Progenics Shares Could Double, According To Cantor
Benzinga's Top Upgrades, Downgrades For July 12, 2017
Progenics Pharmaceuticals Sets Second Quarter —…–7 Financial Results Call for August 9 (GuruFocus)

Exelixis (NASDAQ: EXEL) shares gained 12.78% to $3.75 in pre-market trading after the company reported that coBRIM has met primary endpoint in phase 3 trial.

Progenics Pharmaceuticals (NASDAQ: PGNX) shares surged 11.08% to $4.71 in pre-market trading. Salix Pharmaceuticals (NASDAQ: SLXP) and Progenics reported that the FDA Office of Drug Evaluation III has approved Salix request for the FDA approval of RELISTOR sNDA.

URS (NYSE: URS) shares jumped 7.92% to $56.14 in pre-market trading after Aecom Technology (NYSE: ACM) announced its plans to buy URS for $4 billion in cash and stock.

Mylan (NASDAQ: MYL) shares gained 3.59% to $52.00 in pre-market trading after the company announced its plans to acquire Abbott's (NYSE: ABT) non-U.S. developed markets specialty and branded generics business in a $5.3 billion all-stock transaction.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (ABT + ACM)

View Comments and Join the Discussion!